Assessment of disease activity.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Clinical and Experimental Rheumatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12889221
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria

  2003cited by this paper
• Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.

  2002cited by this paper
• European multicentre study to define disease activity criteria for systemic sclerosis.* II. Identification of disease activity variables and development of preliminary activity indexes

  2001cited by this paper
• Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)

  2001cited by this paper
• Disease assessment indices: activity, damage and severity.

  1995cited by this paper
• Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee.

  1994cited by this paper
• Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity.

  1993cited by this paper
• Alpha interferon-2a (Roferon-A) in the treatment of diffuse cutaneous systemic sclerosis: a pilot study. UK Systemic Sclerosis Study Group.

  1992cited by this paper
• Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil.

  1990cited by this paper
• Serum type III procollagen peptide concentrations in systemic sclerosis and Raynaud's phenomenon: relationship to disease activity and duration.

  1989cited by this paper

• Can we define difficult-to-treat systemic sclerosis?

  2024cites this paper
• Efficacy of rituximab on disease activity, severity, and disease-related damage in patients with immunosuppressive-resistant systemic sclerosis

  2023cites this paper
• Deficiency and altered phenotype of mucosal-associated invariant T cells in systemic sclerosis

  2023cites this paper
• Collagen V α1 Chain Decrease in Papillary Dermis from Early Systemic Sclerosis: A New Proposal in Cutaneous Fibrosis Molecular Structure

  2022cites this paper
• Effects of Fibromyalgia Syndrome in Patients with Diffuse Systemic Sclerosis: Evaluation with 2010 American College of Rheumatology Criteria Set

  2022cites this paper
• Audiological Involvement in Patients with Systemic Sclerosis.

  2021cites this paper
• Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study

  2021cites this paper
• The assessment of malnutrition and severity of gastrointestinal disease by using symptom-based questionnaires in systemic sclerosis: is it related to severe organ involvement or capillary rarefaction at microcirculation?

  2020cites this paper
• Glutathione Transferase P1-1 an Enzyme Useful in Biomedicine and as Biomarker in Clinical Practice and in Environmental Pollution

  2019influential citation
• Systemic sclerosis

  2019cites this paper
• Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.

  2019cites this paper
• Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu

  2018cites this paper
• Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression

  2018cites this paper
• Serum Interleukin 35 Levels in Systemic Sclerosis and Relationship With Clinical Features

  2018cites this paper
• Effect of Corticosteroids and Cyclophosphamide on Sex Hormone Profiles in Male Patients With Systemic Lupus Erythematosus or Systemic Sclerosis

  2017cites this paper
• Molecular markers of systemic autoimmune disorders: the expression of MHC-located HSP70 genes is significantly associated with autoimmunity development.

  2017cites this paper
• [Chronic stress and mental disorders in patients with systemic scleroderma: Results of an interdisciplinary study].

  2017cites this paper
• Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis

  2017cites this paper
• THE INFLUENCE OF HOUSING ENVIRONMENT ON THE MURINE INFLAMMATORY IMMUNE RESPONSE

  2017cites this paper
• Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center

  2016cites this paper
• Brazilian Midwest patients with systemic clerosis lex

  2016cites this paper
• Autoimunidade familial e poliautoimunidade em 60 pacientes portadores de esclerose sistêmica da região Centro‐Oeste do Brasil

  2016cites this paper
• Sobreposição de esclerose sistêmica e artrite reumatoide: uma entidade clínica distinta?

  2016cites this paper
• Anti-Collagen Type V Antibody in Systemic Sclerosis: A Possible Useful Tool to Asses Disease Activity

  2016cites this paper
• verlap between systemic sclerosis and heumatoid arthritis : a distinct clinical entity ? lex

  2016cites this paper
• Summed and Weighted Summary Scores for the Medsger Disease Severity Scale Compared with the Physician’s Global Assessment of Disease Severity in Systemic Sclerosis

  2016cites this paper
• Skin Involvement and Pulmonary Hypertension Are Associated with Vitamin D Insufficiency in Scleroderma

  2016cites this paper
• Disease activity indices in systemic sclerosis: a systematic literature review.

  2016influential citation
• The association of low complement with disease activity in systemic sclerosis: a prospective cohort study

  2016influential citation
• Capillaroscopic findings and vascular biomarkers in systemic sclerosis: Association of low CD40L levels with late scleroderma pattern.

  2016cites this paper
• Familial autoimmunity and polyautoimmunity in 60 Brazilian Midwest patients with systemic sclerosis.

  2016cites this paper
• Subclinical Atherosclerosis in Systemic Sclerosis: Not Less Frequent Than Rheumatoid Arthritis and Not Detected With Cardiovascular Risk Indices

  2016cites this paper
• Overlap between systemic sclerosis and rheumatoid arthritis: a distinct clinical entity?

  2016cites this paper
• Familial autoimmunity and polyautoimmunity in 60 Brazilian Midwest patients with systemic sclerosis.

  2016cites this paper
• Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil

  2015cites this paper
• The relationship between nailfold capillaroscopic assessment and telangiectasia score with severity of peripheral vascular involvement in systemic sclerosis.

  2015cites this paper
• Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease.

  2015cites this paper
• Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment

  2015cites this paper
• [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].

  2015cites this paper
• Association of TRPM Channel Gene Polymorphisms with Systemic Sclerosis.

  2015cites this paper
• Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis.

  2015cites this paper
• University of Groningen Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors Hettema,

  2015cites this paper
• [Overlap between systemic sclerosis and rheumatoid arthritis: a distinct clinical entity?]

  2015cites this paper
• Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk.

  2015cites this paper
• Giant cell arteritis: Current treatment and management.

  2015cites this paper
• Autoanticorpos em esclerose sistêmica e sua correlação com as manifestações clínicas da doença em pacientes do Centro-Oeste do Brasil

  2015cites this paper
• utoantibodies in systemic sclerosis and their linical correlation in patients from a Midwestern egion of Brazil lex

  2015cites this paper
• Epicardial adipose tissue thickness and systemic sclerosis

  2014cites this paper
• Serological profile of patients with systemic sclerosis.

  2014cites this paper
• Serum galectin-3 level in systemic sclerosis

  2014cites this paper
• Health outcomes of pediatric rheumatic diseases.

  2014cites this paper
• The Effect of Quercetin on Plasma Oxidative Status, C-Reactive Protein and Blood Pressure in Women with Rheumatoid Arthritis

  2014cites this paper
• Cells from the skin of patients with systemic sclerosis secrete chitinase 3-like protein 1

  2014influential citation
• S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis

  2014cites this paper
• Seizures in systemic sclerosis

  2013cites this paper
• Whole-lung volume and density in spirometrically-gated inspiratory and expiratory CT in systemic sclerosis: correlation with static volumes at pulmonary function tests.

  2013cites this paper
• Pulmonary hypertension in scleroderma and its relation to disease activity

  2013cites this paper
• Bone Mineral Density, Bone Turnover Markers and Fractures in Patients with Systemic Sclerosis: A Case Control Study

  2013cites this paper
• Erythrocyte glutathione transferase: a non-antibody biomarker for systemic sclerosis, which correlates with severity and activity of the disease

  2013cites this paper
• Artrite reumatóide como modelo de imunossenescência prematura

  2013cites this paper
• Использование международного индекса для оценки активности системной склеродермии

  2013cites this paper
• Chapter 79 – Systemic Sclerosis

  2013cites this paper
• The Assessment of Disease Activity in Rheumatic Diseases

  2013influential citation
• Low Socioeconomic Status (Measured by Education) and Outcomes in Systemic Sclerosis: Data from the Canadian Scleroderma Research Group

  2013cites this paper
• The psychic state of women suffering infertility in the old reproductive age

  2013cites this paper
• Relationship between interleukin-6 and cardiac involvement in systemic sclerosis.

  2013cites this paper
• Detection of autoantibodies in a point-of-care rheumatology setting

  2013cites this paper
• Disease Activity Measures in Paediatric Rheumatic Diseases

  2013cites this paper
• Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study

  2013cites this paper
• Circulating angiopoietin and Tie-2 levels in systemic sclerosis

  2013cites this paper
• Хроническая болезнь почек у пациентов с системной склеродермией: частота встречаемости и факторы, ассоциирующиеся с нарушением функции почек

  2013cites this paper
• Association of C‐reactive protein with high disease activity in systemic sclerosis: Results from the Canadian Scleroderma Research Group

  2012cites this paper
• Patient-Reported Outcomes

  2012cites this paper
• Work participation and work transition in patients with systemic sclerosis: a cross-sectional study.

  2012cites this paper
• Characteristics of Inflammatory Bowel Disease in Three Tertiary Health Centers in Southern Nigeria CaractÈristiques des maladies inflammatoires de lintestin dans 3 centres de santÈ de niveau 3 au sud du Nigeria

  2012cites this paper
• L-selectin and Skin Damage in Systemic Sclerosis

  2012cites this paper
• Increased risk of osteoporosis and fracture in women with systemic sclerosis: A comparative study with rheumatoid arthritis

  2012influential citation
• Characteristics of inflammatory bowel disease in three tertiary health centers in southern Nigeria.

  2012cites this paper
• Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis.

  2012cites this paper
• Measuring fatigue in SSc: a comparison of the Short Form-36 Vitality subscale and Functional Assessment of Chronic Illness Therapy-Fatigue scale.

  2012cites this paper
• An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis

  2011cites this paper
• Serum soluble vascular cell adhesion molecule-1 (sVCAM-1) in scleroderma patients and its relation to pulmonary involvement and disease activity

  2011cites this paper
• ASSESSMENT OF DISEASE ACTIVITY AND EVALUATION OF CLINICAL PARAMETERS AND BIOMARKERS IN SYSTEMIC SCLEROSIS

  2011cites this paper
• In systemic sclerosis macrovascular damage of hands digital arteries correlates with microvascular damage.

  2011cites this paper
• The combination of laser Doppler perfusion imaging and photoplethysmography is useful in the characterization of scleroderma and primary Raynaud's phenomenon

  2011influential citation
• When the heart is burning: amino-terminal pro-brain natriuretic peptide as an early marker of cardiac involvement in active autoimmune rheumatic disease.

  2011cites this paper
• Is Serum Albumin a Marker of Malnutrition in Chronic Disease? The Scleroderma Paradigm

  2010cites this paper
• Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity.

  2010cites this paper
• Bosentan Improves Skin Perfusion of Hands in Patients with Systemic Sclerosis with Pulmonary Arterial Hypertension

  2010cites this paper
• Construct validity evaluation of the European Scleroderma Study Group activity index, and investigation of possible new disease activity markers in systemic sclerosis.

  2010cites this paper
• B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial

  2010cites this paper
• Peripheral T cells from patients with early systemic sclerosis kill autologous fibroblasts in co-culture: is T-cell response aimed to play a protective role?

  2010cites this paper
• Characteristics of Joint Involvement and Relationships with Systemic Inflammation in Systemic Sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) Database

  2010cites this paper
• The Different Photoplethysmographic Patterns Can Help to Distinguish Patients With Primary and Sclerodermic Raynaud Phenomenon

  2010cites this paper
• High DNA Oxidative Damage in Systemic Sclerosis

  2010cites this paper
• Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions.

  2010cites this paper
• Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature.

  2010cites this paper
• Inappropriate exercise-induced increase in pulmonary artery pressure in patients with systemic sclerosis

  2010cites this paper
• Lack of Specificity of the 6-Minute Walk Test as an Outcome Measure for Patients with Systemic Sclerosis

  2009cites this paper
• Syndrome de la tête tombante et sclérodermie systémique

  2009cites this paper